ID S47A1_MOUSE Reviewed; 567 AA. AC Q8K0H1; Q5SS45; Q9CQ64; DT 04-DEC-2007, integrated into UniProtKB/Swiss-Prot. DT 04-DEC-2007, sequence version 2. DT 24-JAN-2024, entry version 141. DE RecName: Full=Multidrug and toxin extrusion protein 1; DE Short=MATE-1; DE Short=mMATE-1; DE AltName: Full=Solute carrier family 47 member 1; GN Name=Slc47a1; Synonyms=Mate1; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). RC STRAIN=C57BL/6J; TISSUE=Liver, and Tongue; RX PubMed=16141072; DOI=10.1126/science.1112014; RA Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N., RA Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K., RA Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J., RA Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R., RA Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T., RA Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A., RA Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., RA Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M., RA Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S., RA Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E., RA Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D., RA Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M., RA Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H., RA Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V., RA Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S., RA Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H., RA Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N., RA Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F., RA Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., RA Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., RA Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C., RA Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y., RA Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S., RA Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K., RA Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R., RA van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H., RA Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M., RA Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C., RA Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S., RA Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K., RA Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M., RA Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C., RA Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A., RA Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.; RT "The transcriptional landscape of the mammalian genome."; RL Science 309:1559-1563(2005). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=C57BL/6J; RX PubMed=19468303; DOI=10.1371/journal.pbio.1000112; RA Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X., RA Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y., RA Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S., RA Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R., RA Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K., RA Eichler E.E., Ponting C.P.; RT "Lineage-specific biology revealed by a finished genome assembly of the RT mouse."; RL PLoS Biol. 7:E1000112-E1000112(2009). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). RC STRAIN=FVB/N; TISSUE=Kidney; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [4] RP TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION. RX PubMed=16330770; DOI=10.1073/pnas.0506483102; RA Otsuka M., Matsumoto T., Morimoto R., Arioka S., Omote H., Moriyama Y.; RT "A human transporter protein that mediates the final excretion step for RT toxic organic cations."; RL Proc. Natl. Acad. Sci. U.S.A. 102:17923-17928(2005). RN [5] RP SUBCELLULAR LOCATION, FUNCTION, TRANSPORTER ACTIVITY, BIOPHYSICOCHEMICAL RP PROPERTIES, AND TISSUE SPECIFICITY. RX PubMed=16641166; DOI=10.1152/ajpcell.00090.2006; RA Hiasa M., Matsumoto T., Komatsu T., Moriyama Y.; RT "Wide variety of locations for rodent MATE1, a transporter protein that RT mediates the final excretion step for toxic organic cations."; RL Am. J. Physiol. 291:C678-C686(2006). RN [6] RP DISRUPTION PHENOTYPE, FUNCTION, AND TRANSPORTER ACTIVITY. RX PubMed=19332510; DOI=10.1124/mol.109.056242; RA Tsuda M., Terada T., Mizuno T., Katsura T., Shimakura J., Inui K.; RT "Targeted disruption of the multidrug and toxin extrusion 1 (mate1) gene in RT mice reduces renal secretion of metformin."; RL Mol. Pharmacol. 75:1280-1286(2009). RN [7] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-18, AND IDENTIFICATION BY RP MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Kidney; RX PubMed=21183079; DOI=10.1016/j.cell.2010.12.001; RA Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R., RA Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.; RT "A tissue-specific atlas of mouse protein phosphorylation and expression."; RL Cell 143:1174-1189(2010). RN [8] RP TISSUE SPECIFICITY. RX PubMed=24961373; DOI=10.1073/pnas.1314939111; RA Chen L., Shu Y., Liang X., Chen E.C., Yee S.W., Zur A.A., Li S., Xu L., RA Keshari K.R., Lin M.J., Chien H.C., Zhang Y., Morrissey K.M., Liu J., RA Ostrem J., Younger N.S., Kurhanewicz J., Shokat K.M., Ashrafi K., RA Giacomini K.M.; RT "OCT1 is a high-capacity thiamine transporter that regulates hepatic RT steatosis and is a target of metformin."; RL Proc. Natl. Acad. Sci. U.S.A. 111:9983-9988(2014). CC -!- FUNCTION: Multidrug efflux pump that functions as a H(+)/organic cation CC antiporter (PubMed:16641166, PubMed:19332510). Plays a physiological CC role in the excretion of cationic compounds including endogenous CC metabolites, drugs, toxins through the kidney and liver, into urine and CC bile respectively (By similarity). Mediates the efflux of endogenous CC compounds such as creatinine, vitamin B1/thiamine, agmatine and CC estrone-3-sulfate (By similarity). May also contribute to regulate the CC transport of cationic compounds in testis across the blood-testis- CC barrier (By similarity). {ECO:0000250|UniProtKB:Q96FL8, CC ECO:0000269|PubMed:16641166, ECO:0000269|PubMed:19332510}. CC -!- CATALYTIC ACTIVITY: CC Reaction=H(+)(in) + thiamine(out) = H(+)(out) + thiamine(in); CC Xref=Rhea:RHEA:71271, ChEBI:CHEBI:15378, ChEBI:CHEBI:18385; CC Evidence={ECO:0000250|UniProtKB:Q96FL8}; CC -!- CATALYTIC ACTIVITY: CC Reaction=estrone 3-sulfate(in) + H(+)(out) = estrone 3-sulfate(out) + CC H(+)(in); Xref=Rhea:RHEA:72139, ChEBI:CHEBI:15378, ChEBI:CHEBI:60050; CC Evidence={ECO:0000250|UniProtKB:Q96FL8}; CC -!- CATALYTIC ACTIVITY: CC Reaction=creatinine(in) + H(+)(out) = creatinine(out) + H(+)(in); CC Xref=Rhea:RHEA:72183, ChEBI:CHEBI:15378, ChEBI:CHEBI:16737; CC Evidence={ECO:0000250|UniProtKB:Q96FL8}; CC -!- CATALYTIC ACTIVITY: CC Reaction=agmatine(in) + H(+)(out) = agmatine(out) + H(+)(in); CC Xref=Rhea:RHEA:72127, ChEBI:CHEBI:15378, ChEBI:CHEBI:58145; CC Evidence={ECO:0000250|UniProtKB:Q96FL8}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:72128; CC Evidence={ECO:0000250|UniProtKB:Q96FL8}; CC PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:72129; CC Evidence={ECO:0000250|UniProtKB:Q96FL8}; CC -!- BIOPHYSICOCHEMICAL PROPERTIES: CC Kinetic parameters: CC KM=0.41 mM for TEA {ECO:0000269|PubMed:16641166}; CC Vmax=0.6 nmol/min/mg enzyme toward TEA {ECO:0000269|PubMed:16641166}; CC pH dependence: CC Optimum pH is 8.0-8.5. Active from pH 6 to 8.5. CC {ECO:0000269|PubMed:16641166}; CC -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:16330770}; CC Multi-pass membrane protein {ECO:0000255}. Apical cell membrane CC {ECO:0000269|PubMed:16330770, ECO:0000269|PubMed:16641166}; Multi-pass CC membrane protein {ECO:0000255}. Note=Localizes to the plasma membrane; CC at the brush border membranes of the proximal tubules (kidney) and at CC the bile caniculi (liver). {ECO:0000250|UniProtKB:Q96FL8}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Name=1; CC IsoId=Q8K0H1-1; Sequence=Displayed; CC Name=2; CC IsoId=Q8K0H1-2; Sequence=VSP_029906, VSP_029907; CC -!- TISSUE SPECIFICITY: Predominantly expressed in kidney and liver CC (PubMed:24961373). Also expressed in various cells, including brain CC glia-like cells and capillaries, pancreatic duct cells, urinary bladder CC epithelium, adrenal gland cortex, heart, stomach, small intestine, CC thyroid gland, testes, alpha cells of the islets of Langerhans, Leydig CC cells, and vitamin A-storing Ito cells. Expressed in heart, stomach, CC small intestine, bladder, thyroid gland, adrenal gland and testes (at CC protein level). {ECO:0000269|PubMed:16330770, CC ECO:0000269|PubMed:16641166, ECO:0000269|PubMed:24961373}. CC -!- DISRUPTION PHENOTYPE: Deficient mice are viable and fertile without any CC overt phenotypical or histological alterations. However, mice exhibit CC increased blood urea nitrogen, increased circulating creatinine, and CC abnormal metformin pharmacokinetics, including increased plasma and CC tissue metformin concentration with decreased kidney and liver CC metformin clearance. {ECO:0000269|PubMed:19332510}. CC -!- MISCELLANEOUS: Mediates the efflux of cationic compounds such as the CC model cations, tetraethylammonium (TEA), the neurotoxin 1-methyl-4- CC phenylpyridinium (MPP), the platinum-based drugs cisplatin and CC oxaliplatin, the drugs procainamide, acyclovir and topotecan, or weak CC bases that are positively charged at physiological pH, such as CC cimetidine or the antidiabetic drug metformin. CC {ECO:0000250|UniProtKB:Q96FL8}. CC -!- SIMILARITY: Belongs to the multi antimicrobial extrusion (MATE) CC (TC 2.A.66.1) family. {ECO:0000305}. CC -!- SEQUENCE CAUTION: CC Sequence=BC031436; Type=Frameshift; Evidence={ECO:0000305}; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AK004994; BAB23729.1; -; mRNA. DR EMBL; AK009038; BAB26040.1; -; mRNA. DR EMBL; AL669884; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; BC031436; -; NOT_ANNOTATED_CDS; mRNA. DR CCDS; CCDS24811.2; -. [Q8K0H1-1] DR RefSeq; NP_080459.2; NM_026183.5. [Q8K0H1-1] DR RefSeq; XP_011247491.1; XM_011249189.2. [Q8K0H1-2] DR AlphaFoldDB; Q8K0H1; -. DR SMR; Q8K0H1; -. DR STRING; 10090.ENSMUSP00000010267; -. DR BindingDB; Q8K0H1; -. DR ChEMBL; CHEMBL3091264; -. DR DrugCentral; Q8K0H1; -. DR TCDB; 2.A.66.1.18; the multidrug/oligosaccharidyl-lipid/polysaccharide (mop) flippase superfamily. DR iPTMnet; Q8K0H1; -. DR PhosphoSitePlus; Q8K0H1; -. DR SwissPalm; Q8K0H1; -. DR jPOST; Q8K0H1; -. DR MaxQB; Q8K0H1; -. DR PaxDb; 10090-ENSMUSP00000010267; -. DR PeptideAtlas; Q8K0H1; -. DR ProteomicsDB; 260794; -. [Q8K0H1-1] DR ProteomicsDB; 260795; -. [Q8K0H1-2] DR Antibodypedia; 13691; 169 antibodies from 30 providers. DR Ensembl; ENSMUST00000010267.10; ENSMUSP00000010267.4; ENSMUSG00000010122.15. [Q8K0H1-1] DR GeneID; 67473; -. DR KEGG; mmu:67473; -. DR UCSC; uc007jhh.2; mouse. [Q8K0H1-2] DR UCSC; uc007jhi.2; mouse. [Q8K0H1-1] DR AGR; MGI:1914723; -. DR CTD; 55244; -. DR MGI; MGI:1914723; Slc47a1. DR VEuPathDB; HostDB:ENSMUSG00000010122; -. DR eggNOG; KOG1347; Eukaryota. DR GeneTree; ENSGT00940000161644; -. DR HOGENOM; CLU_012893_1_3_1; -. DR InParanoid; Q8K0H1; -. DR OMA; WFFVWKL; -. DR OrthoDB; 10858at2759; -. DR PhylomeDB; Q8K0H1; -. DR TreeFam; TF324441; -. DR Reactome; R-MMU-425366; Transport of bile salts and organic acids, metal ions and amine compounds. DR BioGRID-ORCS; 67473; 1 hit in 78 CRISPR screens. DR PRO; PR:Q8K0H1; -. DR Proteomes; UP000000589; Chromosome 11. DR RNAct; Q8K0H1; Protein. DR Bgee; ENSMUSG00000010122; Expressed in renal cortex tubule and 137 other cell types or tissues. DR ExpressionAtlas; Q8K0H1; baseline and differential. DR GO; GO:0016324; C:apical plasma membrane; ISO:MGI. DR GO; GO:0016323; C:basolateral plasma membrane; ISO:MGI. DR GO; GO:0016020; C:membrane; IBA:GO_Central. DR GO; GO:0005886; C:plasma membrane; IDA:UniProtKB. DR GO; GO:0031982; C:vesicle; ISO:MGI. DR GO; GO:0042887; F:amide transmembrane transporter activity; ISO:MGI. DR GO; GO:0015297; F:antiporter activity; IDA:UniProtKB. DR GO; GO:0015179; F:L-amino acid transmembrane transporter activity; ISO:MGI. DR GO; GO:0061459; F:L-arginine transmembrane transporter activity; ISO:MGI. DR GO; GO:0015101; F:organic cation transmembrane transporter activity; ISS:UniProtKB. DR GO; GO:0140968; F:polyspecific organic cation:proton antiporter activity; IDA:UniProtKB. DR GO; GO:0015489; F:putrescine transmembrane transporter activity; ISS:UniProtKB. DR GO; GO:0015234; F:thiamine transmembrane transporter activity; ISS:UniProtKB. DR GO; GO:0042910; F:xenobiotic transmembrane transporter activity; ISO:MGI. DR GO; GO:0097638; P:L-arginine import across plasma membrane; IEA:Ensembl. DR GO; GO:0098655; P:monoatomic cation transmembrane transport; IDA:UniProtKB. DR GO; GO:0006812; P:monoatomic cation transport; ISO:MGI. DR GO; GO:0015695; P:organic cation transport; ISO:MGI. DR GO; GO:0015847; P:putrescine transport; ISS:UniProtKB. DR GO; GO:0055085; P:transmembrane transport; ISO:MGI. DR GO; GO:1990961; P:xenobiotic detoxification by transmembrane export across the plasma membrane; IEA:Ensembl. DR GO; GO:0006855; P:xenobiotic transmembrane transport; IDA:UniProtKB. DR CDD; cd13132; MATE_eukaryotic; 1. DR InterPro; IPR045069; MATE_euk. DR InterPro; IPR002528; MATE_fam. DR NCBIfam; TIGR00797; matE; 1. DR PANTHER; PTHR11206:SF73; MULTIDRUG AND TOXIN EXTRUSION PROTEIN 1; 1. DR PANTHER; PTHR11206; MULTIDRUG RESISTANCE PROTEIN; 1. DR Pfam; PF01554; MatE; 2. DR Genevisible; Q8K0H1; MM. PE 1: Evidence at protein level; KW Acetylation; Alternative splicing; Antiport; Cell membrane; Membrane; KW Phosphoprotein; Reference proteome; Transmembrane; Transmembrane helix; KW Transport. FT CHAIN 1..567 FT /note="Multidrug and toxin extrusion protein 1" FT /id="PRO_0000312846" FT TOPO_DOM 1..37 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 38..58 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 59..72 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 73..93 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 94..120 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 121..141 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 142..152 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 153..173 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 174..187 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 188..208 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 209..216 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 217..237 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 238..257 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 258..277 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 278..295 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 296..316 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 317..336 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 337..357 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 358..370 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 371..391 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 392..408 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 409..429 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 430..437 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 438..458 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 459..543 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 544..564 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 565..567 FT /note="Extracellular" FT /evidence="ECO:0000255" FT MOD_RES 1 FT /note="N-acetylmethionine" FT /evidence="ECO:0000250|UniProtKB:Q96FL8" FT MOD_RES 18 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:21183079" FT VAR_SEQ 1..142 FT /note="Missing (in isoform 2)" FT /evidence="ECO:0000303|PubMed:16141072" FT /id="VSP_029906" FT VAR_SEQ 143..181 FT /note="LFRQDPDVSRLTQTYVMIFIPALPAAFLYTLQVKYLLNQ -> MSDTSPQAG FT VLSRARLLQLRRHSSQRPERSGLAGLLERV (in isoform 2)" FT /evidence="ECO:0000303|PubMed:16141072" FT /id="VSP_029907" SQ SEQUENCE 567 AA; 61642 MW; EDAF1D3DB3BBD8F5 CRC64; MERTEESAPG PGGADAASER RGLRCLLLPG FLEELRALLV LAGPAFLAQL MMFLISFISS VFCGHLGKLE LDAVTLAIAV INVTGISVGH GLSSACDTLI SQTYGSQNLK HVGVILQRGT LILLLCCFPC WALFINTEQI LLLFRQDPDV SRLTQTYVMI FIPALPAAFL YTLQVKYLLN QGIVLPQIMT GIAANLVNAL ANYVFLYHLH LGVMGSALAN TISQFALAIF LFLYILWRRL HQATWGGWSW ECLQDWASFL RLAIPSMLML CIEWWAYEVG SFLSGILGMV ELGAQSITYE LAIIVYMIPS GFSVAANVRV GNALGAGNID QAKKSSAISL IVTELFAVTF CVLLLGCKDL VGYIFTTDRD IVALVAQVIP IYAVSHLFEG LACTCGGILR GTGNQKVGAI VNAIGYYVIG LPIGIALMFA AKLGVIGLWS GIIICTTCQT TCFLAFIARL NWKRACQQAQ VHANLKVNVA LNSAVSHEPA HPVCPESHGE IMMTDLEKKD ETQLDQPMNQ QQALPIRPKD SNKLSGKQLA LRRGLLLLGV VLVLVGGILV RVYIRIE //